Notably, basal cyclin D1 levels were higher in CD133+ cells than matched CD133− cells, whereas cyclin D2 and cyclin E levels were higher in CD133− cells, suggesting that cyclin D1, but not cyclins D2 or E, is critical for the G1/S transition in CD133+ glioma cells. Here, CCND2 is linked to central nervous system cancer.